Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS – Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 14th, there was short interest totaling 3,753 shares, a drop of 80.3% from the July 30th total of 19,077 shares. Based on an average daily trading volume, of 144,592 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.
Neuberger Berman High Yield Strategies Fund Stock Performance
NHS traded down $0.04 on Wednesday, reaching $5.96. 103,854 shares of the stock were exchanged, compared to its average volume of 226,392. Neuberger Berman High Yield Strategies Fund has a fifty-two week low of $5.91 and a fifty-two week high of $7.75. The company’s 50-day moving average price is $6.10 and its 200 day moving average price is $6.54.
Neuberger Berman High Yield Strategies Fund Dividend Announcement
The firm also recently disclosed a monthly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 17th will be paid a dividend of $0.0905 per share. This represents a c) annualized dividend and a yield of 18.2%. The ex-dividend date is Monday, August 17th.
Institutional Trading of Neuberger Berman High Yield Strategies Fund
A number of hedge funds have recently modified their holdings of the stock. Rivernorth Capital Management LLC grew its holdings in Neuberger Berman High Yield Strategies Fund by 2,185.7% during the second quarter. Rivernorth Capital Management LLC now owns 1,371,413 shares of the investment management company’s stock worth $8,558,000 after acquiring an additional 1,311,413 shares during the period. Guggenheim Capital LLC boosted its position in Neuberger Berman High Yield Strategies Fund by 38.0% in the 4th quarter. Guggenheim Capital LLC now owns 567,943 shares of the investment management company’s stock worth $4,225,000 after purchasing an additional 156,386 shares in the last quarter. Invesco Ltd. grew its stake in shares of Neuberger Berman High Yield Strategies Fund by 3.5% during the 2nd quarter. Invesco Ltd. now owns 258,944 shares of the investment management company’s stock worth $1,963,000 after purchasing an additional 8,676 shares during the period. Cable Car Capital LP acquired a new stake in shares of Neuberger Berman High Yield Strategies Fund during the 2nd quarter worth approximately $1,455,000. Finally, Ameriprise Financial Inc. increased its holdings in shares of Neuberger Berman High Yield Strategies Fund by 47.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 117,760 shares of the investment management company’s stock valued at $883,000 after purchasing an additional 37,860 shares in the last quarter.
Neuberger Berman High Yield Strategies Fund Company Profile
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
Featured Articles
- Five stocks we like better than Neuberger Berman High Yield Strategies Fund
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
- Photronics Is Quietly Becoming a Key Winner From the AI Boom
Receive News & Ratings for Neuberger Berman High Yield Strategies Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strategies Fund and related companies with MarketBeat.com's FREE daily email newsletter.
